{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T14:25:12Z","timestamp":1786890312071,"version":"build-2736575974"},"reference-count":49,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Innovation Fund of the Federal Joint Committee","award":["01NVF18028"],"award-info":[{"award-number":["01NVF18028"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Med Decis Making"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mental health intervention studies often lack preference-based measures required to estimate quality-adjusted life-years (QALYs) for health economic evaluations. In such circumstances, a mapping study is the second-best alternative to estimate QALYs. This study aimed to develop a mapping algorithm to predict EQ-5D-5L value sets from the Health of the Nation Outcome Scales (HoNOS) among adults with severe mental illness (SMI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Trial data from a community mental health intervention conducted in Germany between 2020 and 2023 were assessed over 24\u2009mo. The data included more than 900 adults aged 18 to 82\u2009y living with SMI. Four econometric approaches were used to map HoNOS to EQ-5D-5L: ordinary least square (OLS), generalised linear regression model (GLM), fractional regression model (FRM), and an adjusted limited dependent variable mixture model (ALDVMM). The German EQ-5D-5L value set was used, while keeping the Norwegian value set in the\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/journals.sagepub.com\/doi\/suppl\/10.1177\/0272989X261473639\">appendix<\/jats:ext-link>\n                      . Model performance was assessed using the root mean squared error (RMSE), mean absolute error (MAE), and the squared correlation between observed and predicted EQ-5D-5L (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      ). A 10-fold cross-validation was applied to validate our mapping algorithms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The FRM consistently performed best across all evaluation criteria in both the full sample and cross-validation. In cross-validation, when HoNOS items were used as predictors of the German value set, the FRM yielded RMSE = 0.2204, MAE = 0.1622, and\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u00b2 = 36.5%. Similar results were observed when HoNOS subscales were used, with slightly higher RMSE (0.2245) and MAE (0.1664) and a lower\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u00b2 (34.2%). Calibration plots indicated good model fit, with predictions closely aligning with the reference line representing equality between the observed and predicted values. Scatter plots further supported the superior performance of the FRM. A similar pattern was observed for the Norwegian value set.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The preferred mapping algorithm enables the estimation of EQ-5D-5L utilities from HoNOS data, facilitating the calculation of QALYs when only HoNOS information is available. As our sample includes a broad spectrum of mental health patients, further validation within specific diagnostic groups is recommended to improve predictive accuracy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0272989x261473639","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:01:17Z","timestamp":1786690877000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Enabling QALY Estimation in Mental Health Interventions: Mapping the Health of the Nation Outcome Scales onto the EQ-5D-5L"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-421X","authenticated-orcid":false,"given":"Admassu N.","family":"Lamu","sequence":"first","affiliation":[{"name":"A Lamu Consulting, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7395-6535","authenticated-orcid":false,"given":"Egil","family":"Kjerstad","sequence":"additional","affiliation":[{"name":"Department of Economics, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-5787","authenticated-orcid":false,"given":"Reinhold","family":"Kilian","sequence":"additional","affiliation":[{"name":"Section for Health Economics and Health Services Research, Department of Psychiatry II, Ulm University, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2812-5115","authenticated-orcid":false,"given":"Annabel S.","family":"Mueller-Stierlin","sequence":"additional","affiliation":[{"name":"Section for Health Economics and Health Services Research, Department of Psychiatry II, Ulm University, Ulm, Germany"},{"name":"Institute for Epidemiology and Medical Biometry, Ulm University, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Heller T Roccoforte JA Hsieh K Cook JA Pickett SA. Benefits of support groups for families of adults with severe mental illness. Am J Orthopsychiatry. 1997;67(2):187\u2013198. https:\/\/doi.org\/10.1037\/h0080222","DOI":"10.1037\/h0080222"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Rehm J Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21(2):10. https:\/\/doi.org\/10.1007\/s11920-019-0997-0","DOI":"10.1007\/s11920-019-0997-0"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Patel V et al. The Lancet Commission on global mental health and sustainable development. Lancet. 2018;392(10157):1553\u20131598. https:\/\/doi.org\/10.1016\/S0140-6736(18)31612-X","DOI":"10.1016\/S0140-6736(18)31612-X"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Arias D Saxena S Verguet S. Quantifying the global burden of mental disorders and their economic value. EClinical Medicine. 2022;54:101675. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101675","DOI":"10.1016\/j.eclinm.2022.101675"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Konig H et al. Excess costs of mental disorders by level of severity. Soc Psychiatry Psychiatr Epidemiol. 2023;58(6):973\u2013985. https:\/\/doi.org\/10.1007\/s00127-022-02298-8","DOI":"10.1007\/s00127-022-02298-8"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Kinge JM et al. Disease-specific health spending by age sex and type of care in Norway: a national health registry study. BMC Med. 2023;21(1):201. https:\/\/doi.org\/10.1186\/s12916-023-02896-6","DOI":"10.1186\/s12916-023-02896-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Cuijpers P et al. Psychological treatment of depression: a systematic overview of a \u2018Meta-Analytic Research Domain\u2019. J Affect Disord. 2023;335:141\u2013151. https:\/\/doi.org\/10.1016\/j.jad.2023.05.011","DOI":"10.1016\/j.jad.2023.05.011"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Ijaz S et al Psychological therapies for treatment-resistant depression in adults. Cochrane Database Syst Rev. 2018;5(5):CD010558. https:\/\/doi.org\/10.1002\/14651858.CD010558.pub2","DOI":"10.1002\/14651858.CD010558.pub2"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Laugharne R et al. Desperately seeking outcomes: quantifying the effectiveness of community mental healthcare using Health of the Nation Outcome Scales. BJPsych Open. 2018;4(3):91\u201394. https:\/\/doi.org\/10.1192\/bjo.2018.3","DOI":"10.1192\/bjo.2018.3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Slade M Beck A Bindman J Thornicroft G Wright S. Routine clinical outcome measures for patients with severe mental illness: CANSAS and HoNOS. Br J Psychiatry. 1999;174:404\u2013408. https:\/\/doi.org\/10.1192\/bjp.174.5.404","DOI":"10.1192\/bjp.174.5.404"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Delaffon V Anwar Z Noushad F Ahmed AS Brugha TS. Use of Health of the Nation Outcome Scales in psychiatry. Adv Psychiatric Treatment. 2018;18(3):173\u2013179. https:\/\/doi.org\/10.1192\/apt.bp.110.008029","DOI":"10.1192\/apt.bp.110.008029"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Wing J Curtis RH Beevor A. Health of the Nation Outcome Scales (HoNOS): glossary for HoNOS score sheet. Br J Psychiatry. 1999;174:432\u2013434. https:\/\/doi.org\/10.1192\/bjp.174.5.432","DOI":"10.1192\/bjp.174.5.432"},{"key":"e_1_3_2_14_2","unstructured":"Trauer T Buckingham B. The Health of the Nation Outcomes Scales (HoNOS) general adult version: towards an agenda for future development. National Outcomes and Case-mix Collection Discussion Paper. Mental Herath Information Development. 2006."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Wing JK et al Health of the Nation Outcome Scales (HoNOS): research and development. Br J Psychiatry. 1998;172:11\u201318. https:\/\/doi.org\/10.1192\/bjp.172.1.11","DOI":"10.1192\/bjp.172.1.11"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Adams M Palmer A O\u2019Brien JT Crook W. Health of the Nation Outcome Scales for psychiatry: are they valid? J Ment Health. 2000;9(2):193\u2013198. https:\/\/doi.org\/10.1080\/09638230050009186","DOI":"10.1080\/09638230050009186"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"McClelland R Trimble P Fox ML Stevenson MR Bell B. Validation of an outcome scale for use in adult psychiatric practice. Qual Health Care. 2000;9(2):98\u2013105. https:\/\/doi.org\/10.1136\/qhc.9.2.98","DOI":"10.1136\/qhc.9.2.98"},{"key":"e_1_3_2_18_2","unstructured":"Brazier J. Measuring and valuing health benefits for economic evaluation. Oxford University Press; 2009."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Devlin NJ Brooks R. EQ-5D and the EuroQol Group: past present and future. Appl Health Econ Health Policy. 2017;15(2):127\u2013137. https:\/\/doi.org\/10.1007\/s40258-017-0310-5","DOI":"10.1007\/s40258-017-0310-5"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Kennedy-Martin M et al. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur J Health Econ. 2020;21(8):1245\u20131257. https:\/\/doi.org\/10.1007\/s10198-020-01195-8","DOI":"10.1007\/s10198-020-01195-8"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","unstructured":"Shaw C Longworth L Bennett B McEntee-Richardson L Shaw JW. A review of the use of EQ-5D for clinical outcome assessment in health technology assessment regulatory claims and published literature. Patient. 2024;17(3):239\u2013249. https:\/\/doi.org\/10.1007\/s40271-023-00662-7","DOI":"10.1007\/s40271-023-00662-7"},{"key":"e_1_3_2_22_2","unstructured":"NICE. Guide to the methods of technology appraisal 2013. National Institute for Health and Care Excellence 2013; [accessed 2026 Oct 20]. https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/foreword"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Webb EJD. An item-response mapping from general health questionnaire responses to EQ-5D-3L using a general population sample from England. Appl Health Econ Health Policy. 2023;21(2):327\u2013346. https:\/\/doi.org\/10.1007\/s40258-022-00767-4","DOI":"10.1007\/s40258-022-00767-4"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Kleijburg A et al. Mapping of the Health of the Nation Outcomes Scale (HoNOS) and Positive and Negative Symptom Scale (PANSS) to the EQ-5D-3L in psychosis patients using the PHAMOUS study. Expert Rev Pharmacoecon Outcomes Res. 2025;25(3):373\u2013384. https:\/\/doi.org\/10.1080\/14737167.2024.2422456","DOI":"10.1080\/14737167.2024.2422456"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Herdman M et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u20131736. https:\/\/doi.org\/10.1007\/s11136-011-9903-x","DOI":"10.1007\/s11136-011-9903-x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"Mueller-Stierlin AS et al. Results from a randomized controlled trial investigating effectiveness of a community-based intervention on empowerment of people with severe mental illness. Soc Psychiatry Psychiatr Epidemiol. 2025;60:2135\u20132147. https:\/\/doi.org\/10.1007\/s00127-025-02879-3","DOI":"10.1007\/s00127-025-02879-3"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Mueller-Stierlin AS et al. Effectiveness and cost-effectiveness of a community-based mental health care programme (GBV) for people with severe mental illness in Germany: study protocol for a randomised controlled trial. Trials. 2020;21(1) 598. https:\/\/doi.org\/10.1186\/s13063-020-04492-y","DOI":"10.1186\/s13063-020-04492-y"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Parabiaghi A Kortrijk HE Mulder CL. Defining multiple criteria for meaningful outcome in routine outcome measurement using the Health of the Nation Outcome Scales. Soc Psychiatry Psychiatr Epidemiol. 2014;49(2):291\u2013305. https:\/\/doi.org\/10.1007\/s00127-013-0750-7","DOI":"10.1007\/s00127-013-0750-7"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","unstructured":"Ludwig K Graf von der Schulenburg JM Greiner W. German value set for the EQ-5D-5L. Pharmacoeconomics. 2018;36(6):663\u2013674. https:\/\/doi.org\/10.1007\/s40273-018-0615-8","DOI":"10.1007\/s40273-018-0615-8"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","unstructured":"Garratt AM Stavem K Shaw JW Rand K. EQ-5D-5L value set for Norway: a hybrid model using cTTO and DCE data. Qual Life Res. 2025;34(2):417\u2013427. https:\/\/doi.org\/10.1007\/s11136-024-03837-3","DOI":"10.1007\/s11136-024-03837-3"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","unstructured":"Royston P et al. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604. https:\/\/doi.org\/10.1136\/bmj.b604","DOI":"10.1136\/bmj.b604"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Chowdhury MZI Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020;8(1):e000262. https:\/\/doi.org\/10.1136\/fmch-2019-000262","DOI":"10.1136\/fmch-2019-000262"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","unstructured":"Ara R Rowen D Mukuria C. The use of mapping to estimate health state utility values. Pharmacoeconomics. 2017;35(s1):57\u201366. https:\/\/doi.org\/10.1007\/s40273-017-0548-7","DOI":"10.1007\/s40273-017-0548-7"},{"key":"e_1_3_2_34_2","unstructured":"Fox J. Applied regression analysis and generalized linear models. 3rd ed. Sage; 2015."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","unstructured":"Papke LE. Econometric methods for fractional response variables with an application to 401 (k) plan participation rates. J Appl Econ. 1996;11(6):619\u2013632. https:\/\/doi.org\/10.1002\/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1","DOI":"10.1002\/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","unstructured":"Lamu AN Chen G Gamst-Klaussen T Olsen JA. Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets. Qual Life Res. 2018;27(7):1801\u20131814. https:\/\/doi.org\/10.1007\/s11136-018-1840-5","DOI":"10.1007\/s11136-018-1840-5"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez Alava M Wailoo A. Fitting adjusted limited dependent variable mixture models to EQ-5D. Stata J. 2015;15(3):737\u2013750. https:\/\/doi.org\/10.1177\/1536867x1501500307","DOI":"10.1177\/1536867X1501500307"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","unstructured":"McLachlan GJ Lee SX Rathnayake SI. Finite mixture models. Ann Rev Stat Appl. 2019;6(1):355\u2013378. https:\/\/doi.org\/10.1146\/annurev-statistics-031017-100325","DOI":"10.1146\/annurev-statistics-031017-100325"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez Alava M Wailoo AJ Ara R. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health. 2012;15(3):550\u2013561. https:\/\/doi.org\/10.1016\/j.jval.2011.12.014","DOI":"10.1016\/j.jval.2011.12.014"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","unstructured":"Brazier JE Yang Y Tsuchiya A Rowen DL. A review of studies mapping (or cross walking) non-preference-based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215\u2013225. https:\/\/doi.org\/10.1007\/s10198-009-0168-z","DOI":"10.1007\/s10198-009-0168-z"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","unstructured":"Longworth L et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review statistical modelling and survey. Health Technol Assess. 2014;18(9):1\u2013224. https:\/\/doi.org\/10.3310\/hta18090","DOI":"10.3310\/hta18090"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Versteegh MM. Mapping QLQ-C30 HAQ and MSIS-29 on EQ-5D. Med Decis Making. 2012;32(4):554\u2013568. https:\/\/doi.org\/10.1177\/0272989X11427761","DOI":"10.1177\/0272989X11427761"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","unstructured":"Gerds TA Andersen PK Kattan MW. Calibration plots for risk prediction models in the presence of competing risks. Stat Med. 2014;33(18):3191\u20133203. https:\/\/doi.org\/10.1002\/sim.6152","DOI":"10.1002\/sim.6152"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","unstructured":"Aghdaee M et al. An examination of machine learning to map non-preference based patient reported outcome measures to health state utility values. Health Econ. 2022;31(8):1525\u20131557. https:\/\/doi.org\/10.1002\/hec.4503","DOI":"10.1002\/hec.4503"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","unstructured":"Wailoo A Pudney S Gray L Manca A Alava MH. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods. Health Technol Assess. 2020;24(34):1\u201394. https:\/\/doi.org\/10.3310\/hta24340","DOI":"10.3310\/hta24340"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","unstructured":"Petrou S et al. The MAPS reporting statement for studies mapping onto generic preference-based outcome measures: explanation and elaboration. Pharmacoeconomics. 2015;33(10):993\u20131011. https:\/\/doi.org\/10.1007\/s40273-015-0312-9","DOI":"10.1007\/s40273-015-0312-9"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","unstructured":"Lindkvist M Feldman I. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L. Health Qual Life Outcomes. 2016;14(1):1\u20139. https:\/\/doi.org\/10.1186\/s12955-016-0535-2","DOI":"10.1186\/s12955-016-0535-2"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","unstructured":"Siani C de Peretti C Millier A Boyer L Toumi M. Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC. Qual Life Res. 2016;25(4):925\u2013934. https:\/\/doi.org\/10.1007\/s11136-015-1120-6","DOI":"10.1007\/s11136-015-1120-6"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","unstructured":"Sharma D Aggarwal AK Downey LE Prinja S. National healthcare economic evaluation guidelines: a cross-country comparison. Pharmacoecon Open. 2021;5(3):349\u2013364. https:\/\/doi.org\/10.1007\/s41669-020-00250-7","DOI":"10.1007\/s41669-020-00250-7"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","unstructured":"Longworth L Rowen D. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health. 2013;16(1):202\u2013210. https:\/\/doi.org\/10.1016\/j.jval.2012.10.010","DOI":"10.1016\/j.jval.2012.10.010"}],"container-title":["Medical Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X261473639","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0272989X261473639","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X261473639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T13:47:29Z","timestamp":1786888049000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0272989X261473639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":49,"alternative-id":["10.1177\/0272989X261473639"],"URL":"https:\/\/doi.org\/10.1177\/0272989x261473639","relation":{},"ISSN":["0272-989X","1552-681X"],"issn-type":[{"value":"0272-989X","type":"print"},{"value":"1552-681X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"0272989X261473639"}}